Posts by: Anna Tan, RN

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

December 29, 2014December 29, 2014

Mirati Therapeutics Treats 1st Lung CA Patient in Anti-Tumor Drug Study

Lung Cancer, News

Precision medicine drug developer, Mirati Therapeutics, Inc., recently announced it has treated the first patient volunteer in a Phase Ib clinical study of MGCD265 for Non-Small Cell Lung Cancer (NSCLC) with genetic mutations of MET ... Read more

December 19, 2014December 19, 2014

Coming Soon: Smartwatch that Monitors SpO2 and Vital Signs in COPD

News

Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika ... Read more

December 16, 2014December 16, 2014

Glyconics to Co-Develop Portable IR Spectroscopy for COPD Diagnostics

News

Cardiff, UK-based diagnostics company Glyconics Ltd. has just announced it has closed on an exclusive licensing agreement with Swansea University for the use of their proprietary Infrared Spectroscopy to diagnose chronic obstructive pulmonary ... Read more

December 15, 2014November 6, 2015

Enrollment Ongoing for Canadian Study on Asthma Treatment Compliance

Asthma, News

One of the challenges asthma patients face is medication compliance, as many require long-term or even lifelong treatment and maintenance. Oftentimes, these medications would successfully induce remission, which would prompt ... Read more

December 12, 2014December 12, 2014

Nintedanib by Boehringer Approved in EU as Second-Line NSCLC Treatment

Lung Cancer, News

Drug maker Boehringer Ingelheim has announced that the European Commission granted Vargatef® (nintedanib) marketing approval in 28 EU countries. Together with docetaxel, it is indicated for the post-chemotherapy treatment of either locally ... Read more

December 11, 2014November 5, 2015

iBio Releases Updates on Promising IPF and SSc Pipeline Treatment

Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

iBio, Inc., a specialist in developing plant-based therapeutics, hosted shareholders and attendees at its Annual Meeting on Thursday, December 11, and presented a comprehensive update on the company’s ongoing activities ... Read more

December 11, 2014November 6, 2015

Medavie Offers Patient Support Services for Asthma and COPD

Asthma, News

The Canadian Society of Respiratory Therapists (CSRT) recently applauded Medavie Blue Cross for actively providing practical health promotion initiatives to patients with asthma and/or chronic obstructive pulmonary disease (COPD) in a new ... Read more

December 10, 2014November 11, 2015

Cureveda Receives NIH Grants for Systemic Sclerosis and COPD Drug

COPD, News, Scleroderma

Biotechnology company Cureveda LLC just announced that it has received two National Institutes of Health (NIH) Phase I Small Business Technology Transfer (STTR) grants worth $450,000 in total. Cureveda specializes in ... Read more

December 10, 2014October 28, 2015

Indoor Air Quality Experts Identify Asthma Triggers

News

The United States economy spends about $56 billion health dollars on asthma and asthma-related complications each year. This chronic respiratory condition remains incurable, but is reasonably managed in many patients ... Read more

December 9, 2014December 9, 2014

Cepheid Diagnostic Test FDA Approved to Identify Flu A, B, and RSV

Bronchiolitis, News

Sunnyvale, California-based molecular diagnostics company, Cepheid, has just announced the US Food and Drug Administration has granted marketing clearance for its proprietary Xpert® Flu/RSV XC, a breakthrough diagnostic tool that can differentiate ... Read more